Thaker PH, Richardson DL, Hagemann AR, Holloway RW, et al. Corrigendum to 'OVATION-2: A randomized phase I/II study evaluating the safety
and efficacy of IMNN-001 (IL-12 gene therapy) with neo/adjuvant chemotherapy in
patients newly-diagnosed with advanced epithelial ovarian cancer' [Gynecol Oncol
2025 Jun 19 Gynecol Oncol 2025;203:182-183.
PMID: 41202407
|